Literature DB >> 8553637

What physicians should know about Africanized honeybees.

R A Sherman1.   

Abstract

The Africanized honeybee, popularly known as the "killer bee," is already well established in Texas and has recently entered California and Arizona. As the Africanized honeybee spreads in North America, the medical community must become aware of the problems associated with this insect and ensure that sting emergencies can be handled quickly and appropriately. The major differences between Africanized and European honeybees are that the former are more irritable, they swarm more readily and frequently, they defend their hives more vehemently, and they sting more collectively. It is not the composition nor the volume of an individual bee's venom, but rather the cumulative dose of multiple stings that accounts for the morbidity and mortality associated with Africanized honeybee-sting incidents. Even nonallergic persons are susceptible to the toxic effects of these large combined venom loads. Africanized honeybee-sting victims are treated the same as victims of European honeybee stings. Authorities will prepare for the bees' arrival by expanding public awareness, teaching risk-avoidance behavior, providing for the removal of troublesome hives, and developing sting treatment protocols that can be initiated rapidly in the field or emergency departments. Health care professionals should participate in the educational efforts and in the development of needed emergency response protocols so that the effects of the Africanized honeybee will be merely a nuisance rather than a plague.

Entities:  

Mesh:

Year:  1995        PMID: 8553637      PMCID: PMC1303260     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  37 in total

1.  Anaphylaxis and stinging insect hypersensitivity.

Authors:  M D Valentine
Journal:  JAMA       Date:  1992-11-25       Impact factor: 56.272

2.  Identification of isoamyl acetate as an active component in the sting pheromone of the honey bee.

Authors:  R BOCH; D A SHEARER; B C STONE
Journal:  Nature       Date:  1962-09-08       Impact factor: 49.962

3.  Unusual reactions following insect stings. Clinical features and immunologic analysis.

Authors:  W C Light; R E Reisman; M Shimizu; C E Arbesman
Journal:  J Allergy Clin Immunol       Date:  1977-05       Impact factor: 10.793

4.  Immunotherapy for allergy to insect stings.

Authors:  R F Lockey
Journal:  N Engl J Med       Date:  1990-12-06       Impact factor: 91.245

5.  Hymenoptera venom-specific IgE antibodies in post-mortem sera from victims of sudden, unexpected death.

Authors:  H J Schwartz; C Sutheimer; M B Gauerke; J W Yunginger
Journal:  Clin Allergy       Date:  1988-09

6.  Lethality of 'killer' bee stings.

Authors:  M J Schumacher; J O Schmidt; N B Egen
Journal:  Nature       Date:  1989-02-02       Impact factor: 49.962

7.  For those who treat spider or suspected spider bites.

Authors:  F E Russell; W J Gertsch
Journal:  Toxicon       Date:  1983       Impact factor: 3.033

8.  Epidemiology of insect venom sensitivity.

Authors:  D B Golden; D G Marsh; A Kagey-Sobotka; L Freidhoff; M Szklo; M D Valentine; L M Lichtenstein
Journal:  JAMA       Date:  1989-07-14       Impact factor: 56.272

9.  Colony defense by africanized and European honey bees.

Authors:  A M Collins; T E Rinderer; J R Harbo; A B Bolten
Journal:  Science       Date:  1982-10-01       Impact factor: 47.728

Review 10.  Emergency treatment of allergic reactions to Hymenoptera stings.

Authors:  U Müller; H Mosbech; P Blaauw; S Dreborg; H J Malling; B Przybilla; R Urbanek; E Pastorello; M Blanca; J Bousquet
Journal:  Clin Exp Allergy       Date:  1991-05       Impact factor: 5.018

View more
  2 in total

1.  Cavernous sinus thrombosis following bee sting.

Authors:  Subramanian Senthilkumaran; Namasivayam Balamurugan; Shah Sweni; Ponniah Thirumalaikolundusubramanian
Journal:  Int J Crit Illn Inj Sci       Date:  2011-07

Review 2.  Bee Updated: Current Knowledge on Bee Venom and Bee Envenoming Therapy.

Authors:  Manuela B Pucca; Felipe A Cerni; Isadora S Oliveira; Timothy P Jenkins; Lídia Argemí; Christoffer V Sørensen; Shirin Ahmadi; José E Barbosa; Andreas H Laustsen
Journal:  Front Immunol       Date:  2019-09-06       Impact factor: 7.561

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.